It's looking up for Beverly biotech firm
474606
So what's a dog's life like, anyhow? Scientists at Agencourt Bioscience Corp. in Beverly know. The biotech company helped to sequence the genetic coding that makes a dog a dog. Last month, the data was added to several public databases, making it available to biomedical and veterinary researchers around the world.
549362
(Indianapolis-December 8, 2004) - As the City of Indianapolis tries to build an image as a center for the life sciences, one of its premiere biotechnology companies could be leaving.
752070
Keep an eye on this small-cap industrial equipment firm.
298677
With a new governor set to take office in January and the world's largest biotechnology convention headed to Boston next spring, leaders of universities and local biotech businesses are meeting this morning to try to launch a lobbying group and think tank that would unite life-science companies, academic laboratories, and hospitals.
479126
Strong drug sales provide a dose of good medicine for this pharmaceutical company.
326432
Bio-Reference again showed it can compete with larger archrivals.
725261
There's encouraging news about an enzyme replacement drug.
128486
By Jean Paul Vellotti  With a $700 million, 872,000-square-foot biotech incubator possibly breaking ground in New York City before 2007, local bioscience experts are thinking big.
751523
A new addition to an already successful drug promises good results for investors.
649836
Myriad Genetics' innovative technology creates an investment opportunity.
84465
An international pharmaceutical company is eyeing Lexington as its new center of operations for genetic therapies, promising hundreds of high-paying jobs and a $394 million investment over the next four years.
272859
Genizon, a Canadian biotech company, gets an infusion of cash to develop personalized medicine for metabolic disorders, including obesity and diabetes.
435276
The troubled pharmaceutical company begins to show signs of life.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
447760
Hard-earned tips from a biotech investor.
640990
Now might be a great time to load up on cutting-edge drug makers.
559256
By Luke Timmerman, Seattle Times  Sep. 21--Frazier Healthcare Ventures has hired a crew of big-name biotech and pharmaceutical executives to help figure out how to get more bang for its bucks in drugs and medical devices.